Promino Nutritional Sciences Inc.
MUSLF
$0.02
-$0.01-25.56%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 70.15% | 317.33% | 718.00% | 583.23% | 199.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.15% | 317.33% | 718.00% | 583.23% | 199.21% |
| Cost of Revenue | 40.48% | 128.49% | 182.83% | 55.32% | -39.78% |
| Gross Profit | 192.58% | 219.67% | 232.81% | 119.56% | 91.73% |
| SG&A Expenses | 66.74% | -17.18% | -46.44% | -93.63% | -79.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.21% | 4.52% | -27.49% | -81.45% | -71.36% |
| Operating Income | -43.39% | 31.27% | 56.26% | 94.87% | 80.17% |
| Income Before Tax | 24.53% | 38.40% | 58.92% | 90.53% | 67.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.53% | 38.40% | 58.92% | 90.53% | 67.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.53% | 38.40% | 58.92% | 90.53% | 67.21% |
| EBIT | -43.39% | 31.27% | 56.26% | 94.87% | 80.17% |
| EBITDA | -- | -- | -- | 110.89% | 94.56% |
| EPS Basic | 46.34% | 66.52% | 80.55% | 96.23% | 85.56% |
| Normalized Basic EPS | 13.79% | 55.43% | 76.13% | 95.13% | 87.87% |
| EPS Diluted | 41.01% | 63.44% | 78.70% | 96.26% | 84.72% |
| Normalized Diluted EPS | 13.79% | 55.43% | 76.13% | 95.13% | 87.87% |
| Average Basic Shares Outstanding | 34.46% | 44.01% | 58.59% | 94.78% | 70.91% |
| Average Diluted Shares Outstanding | 34.46% | 44.01% | 58.59% | 94.78% | 70.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |